Ali Ansary

Ali Ansary is a medical student at Rocky Vista University, where his drive and passion have come from developing and driving new technologies that improve the overall healthcare of patients and their community. Ansary earned his undergraduate degree at the University of California, Berkeley and his master’s at the University of Cambridge, UK where he focused on new and emerging technologies and translating research from the benchside to the bedside. Ansary lead a team to focus on developing a subdermal drug delivery device for tuberculosis to address the issue of noncompliance. CNN highlighted the concept as one of the “six ideas that could change the world.” Ansary spent time working on his master’s dissertation in collaboration with the Healthcare Advisory group at PriceWaterhouseCoopers in Dubai, UAE and the Abu Dhabi Health Authority, UAE on how to create affordable and accessible medicines in the Gulf Cooperation Council (GCC). After Cambridge, Ansary worked at the World Health Organization in the Department of Nutrition for Health and Development. Ansary is co-founder of SeventyK, a non-profit working to discover new ways to address the disparity that exists with adolescent and young adults with cancer. In 2010, Ansary became an Ariane de Rothschild Fellow, a prestigious network of international entrepreneurs with a demonstrated interest in social change and cross-cultural dialogue.

So technology is a crutch…you got a problem with that? (Ali Ansary)

Science Kit for Ali Ansary

Thank you for requesting my Science Kit! 

My goal as a medical student and future healthcare practitioner is to prepare for healthcare in the 21st century and provide the best care inside and outside of the clinic. 

One way has been by addressing the disparities that exist in young people with cancer through an organization I helped co-found called SeventyK. SeventyK represents the number of young people diagnosed with cancer in the US alone. We are constantly working to try novel strategies to reach young people and improve cancer outcomes and survivorship. (

The gist of my talk was that we’ve become used to seeing next-generation technology arriving every day.

New preventive innovations will take traditional technology into behavioral applications. Imagine subdermal drug delivery devices communicating with cells that have their own IP address. Tomorrow’s most exciting medical technology will not be about treating disease; it will be about maintaining health. We are beginning to live in a society where a patient’s health care is no longer bound by the walls of a clinic. New technologies will help patients “do no harm” to themselves. 

Would love to chat more, feel free to connect w/ me @